This is documented in Oncology Nursing News.... Darolutamide Shows Less Cognitive Decline Than Enzalutamide in Advanced Prostate Cancer.
When a man goes on hormone therapy for prostate cancer - the focus is almost always on the cancer. Is it working? Are the numbers moving? Good. What next?
Nobody talks about the brain.
New research has looked at two of the most commonly used hormone therapy drugs and compared how they affect cognition. The difference is significant. One causes measurably more cognitive decline than the other.
For the men here who are on treatment, or whose partners are watching for changes - this is not something you imagined. It is biology. And it is something to raise with your doctor.
Has anyone in the community experienced this? Or noticed it in someone they care about? I would genuinely like to know what people have seen.